Results 151 to 160 of about 23,600 (247)

ATM inhibition decreases ERK activation and is synergistic with ibrutinib in primary chronic lymphocytic leukemia cells. [PDF]

Blood Adv
Kost SEF, Saleh A, Brown J, Yuan SH, Kuzio B, Yang L, Banerji V, Gibson SB, Johnston JB, Katyal S.   +9 more
europepmc   +1 more source

Real-world study on patient characteristics, treatment patterns and outcomes for treated patients with chronic lymphocytic leukemia during 2013-2022 in Finland. [PDF]

Ann Hematol
Ranti J, Jamalzadeh S, Mäkelä E, Vikkula J, Havula E, Luopajärvi S, Lindström V.   +6 more
europepmc   +1 more source

Antiproliferative activities of phytochemicals isolated from the leaves of Dolichos kilimandischaricus (Harms) ex Taub. (Fabaceae) on Jurkat and HL-60 leukemic cells. [PDF]

BMC Complement Med Ther
Sithole S, Mushonga P, Heydenreich M, Mawere C, Mukanganyama S.   +4 more
europepmc   +1 more source

Disseminated Bacillus Calmette-Guerin infection following concurrent intravesical BCG therapy and immune checkpoint inhibitior therapy: a case report. [PDF]

BMC Infect Dis
Plymoth M, C CW, Harvey R, Crighton T, Sandaradura I.   +4 more
europepmc   +1 more source

Use of Immunosuppression, Romiplostim, and Splenectomy to Achieve Remission in a British Shorthair Cat With Primary Immune-Mediated Thrombocytopenia. [PDF]

J Vet Intern Med
Kennils JM, Wilson HE.
europepmc   +1 more source

First-line treatment for CLL in the era of targeted therapy. [PDF]

Blood Cancer J
Davids MS, Stilgenbauer S, Tam CS.
europepmc   +1 more source

Clinical Patterns and Prognostic Outcomes of Asian Ocular Adnexal Marginal Zone Lymphoma. [PDF]

J Hematol
Kwan RLY, Lim RMH, Chan JY.
europepmc   +1 more source

2D and 3D anticancer activity of diiron bis-cyclopentadienyl complexes incorporating flurbiprofen and chlorambucil. [PDF]

RSC Med Chem
Biancalana L, De Franco M, Gandin V, Marchetti F.   +3 more
europepmc   +1 more source

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of chronic lymphocytic leukemia [PDF]

, 2017
Greil, R., Hallek, M., Stahel, R. A.
core  

Hepatitis B virus reactivation in patients with hematologic malignancies treated with Bruton tyrosine kinase inhibitors. [PDF]

Blood Res
Hur JY, Lee JH, Lee JH, Park HS, Park H, Choi Y, Choi JH, Won YW, Yoon SE, Kim WS, Kim SJ.   +10 more
europepmc   +1 more source